Description
Klow blend research peptide material combines four research compounds — BPC-157 (10mg), GHK-Cu (50mg), TB-500 (10mg), and KPV (80mg) — in a single 3ml vial, supplied for laboratory and non-clinical investigation of combined tissue-repair and dermal research pathways.
What Is the Klow Blend
The Klow blend research peptide formulation pairs BPC-157 and TB-500, both studied for tissue-repair and cellular-migration mechanisms, with GHK-Cu, a copper-binding tripeptide studied in dermal and connective-tissue research, and KPV, a tripeptide fragment of alpha-MSH studied for anti-inflammatory pathway research. This four-compound combination is used by laboratories investigating overlapping and complementary research pathways across in vitro and animal-model systems.
Research Applications (laboratory / non-clinical research only)
- Animal model research into combined tissue-repair and dermal-matrix pathways
- In vitro studies of angiogenesis, collagen synthesis, and anti-inflammatory signaling
- Preclinical investigation of multi-peptide combination research protocols
- Comparative research into combined-peptide versus single-peptide research pathways
- Laboratory studies of cellular migration and extracellular matrix remodeling
Quality & Sourcing
This Klow blend research peptide material is manufactured to high purity standards and verified by HPLC (High-Performance Liquid Chromatography) analysis. Each batch is lyophilized for stability, and a Certificate of Analysis (COA) is available on request confirming peptide identity and purity. Material is intended for use by qualified researchers in controlled laboratory environments only.
Supplied As
Supplied as a lyophilized four-compound blend (BPC-157 10mg, GHK-Cu 50mg, TB-500 10mg, KPV 80mg) in a 3ml vial, suitable for standard laboratory reconstitution procedures performed by trained personnel for research purposes.
Molecular Characteristics
The Klow blend combines four distinct research peptides in a single formulation: BPC-157, a synthetic pentadecapeptide; TB-500, the active fragment of thymosin beta-4; GHK-Cu, a copper-binding tripeptide; and KPV, a tripeptide fragment derived from alpha-MSH studied for anti-inflammatory pathway research. Combining four compounds with different mechanisms into one lyophilized vial is intended to simplify laboratory handling for researchers investigating overlapping tissue-repair, dermal, and anti-inflammatory pathways within a single protocol, rather than requiring separate procurement and reconstitution of each peptide individually.
Handling & Storage Considerations
Lyophilized Klow blend material should be stored in a freezer (-20°C or below), protected from light and moisture, until the researcher is ready to reconstitute the material for a laboratory protocol. Once reconstituted with bacteriostatic water, the solution is generally stored refrigerated (2-8°C) and used within the window supported by internal stability testing. Because this formulation combines multiple peptide classes, including a copper-binding tripeptide, researchers generally take extra care to avoid repeated freeze-thaw cycles and prolonged light exposure to preserve the integrity of all four components.
Common Research Design Considerations
Laboratories investigating multi-compound blends such as Klow commonly design animal-model studies evaluating combined tissue-repair and dermal-matrix pathways, comparing outcomes against single-compound administration of each constituent peptide. In vitro research frequently uses cultured cell models to assess angiogenesis, collagen synthesis, and anti-inflammatory signaling markers following exposure to the combined formulation. Comparative study designs often examine Klow alongside the related Glow blend and individual constituent peptides to characterize combination-specific research outcomes.
Frequently Asked Questions
Is this compound stable at room temperature?
Short-term handling at room temperature during active laboratory use is generally acceptable, but the lyophilized material should be returned to frozen storage promptly to preserve research-grade integrity across all four components.
What purity level should researchers expect?
Material is verified by HPLC analysis at the time of batch testing, with purity data available via the accompanying Certificate of Analysis.
Is a Certificate of Analysis provided?
Yes, a COA is available on request for each batch, confirming identity and purity for research documentation purposes.
Related Compounds
Researchers investigating the Klow blend often also study the related Glow blend, as well as the individual constituent peptides BPC-157, TB-500, and GHK-Cu, to compare combined-formulation and single-compound research outcomes.
For research use only. Not for human or veterinary use. Not a drug, supplement, or therapeutic product. Not intended to diagnose, treat, cure, or prevent any condition.




